Leukotriene Receptor Antagonists Inhibit Mitogenic Activity in Triple Negative Breast Cancer Cells

Despite a discovery of hormonal pathways regulating breast cancer, a definitive cure for the disease requires further identification of alternative targets that provide a hormone-independent support. Apart from their role in inflammatory diseases, cysteinyl leukotriene (CysLT) receptor antagonists (...

Descripción completa

Detalles Bibliográficos
Autores principales: Suknuntha, Kran, Yubolphan, Ruedeemars, Krueaprasertkul, Kanokpan, Srihirun, Sirada, Sibmooh, Nathawut, Vivithanaporn, Pornpun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980863/
https://www.ncbi.nlm.nih.gov/pubmed/29582642
http://dx.doi.org/10.22034/APJCP.2018.19.3.833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980863/
https://www.ncbi.nlm.nih.gov/pubmed/29582642
http://dx.doi.org/10.22034/APJCP.2018.19.3.833

Ejemplares similares